SCHEMBL8286344

SCHEMBL8286344

Cc1cc(N2CCN(c3ccccc3)CC2)nc2c1c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.64
PIK3CD O00329 1/20 0.42
PIK3CA P42336 1/20 0.42
PIK3CB P42338 1/20 0.42
CDK4 P11802 1/20 0.42
CCND1 P24385 1/20 0.42
CCND2 P30279 1/20 0.42
CCND3 P30281 1/20 0.42
MAPT P10636 9/20 0.40
KDM4E B2RXH2 5/20 0.40
TSHR P16473 2/20 0.40
HSD17B10 Q99714 2/20 0.40
GFER P55789 1/20 0.40
LMNA P02545 1/20 0.40
MAPK1 P28482 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
TP53 P04637 1/20 0.39
ALOX15 P16050 1/20 0.39
POLB P06746 1/20 0.39
GALR2 O43603 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285166 0.95 PDE11A (0.60) PDE11APIK3CDPIK3CAPIK3CBCDK4
SCHEMBL8286346 0.94 PDE11A (0.61) PDE11APIK3CDPIK3CAPIK3CBMAPT
SCHEMBL5872109 0.93 PDE11A (0.75) PDE11APIK3CDPIK3CAPIK3CBMAPT
SCHEMBL8286342 0.93 PDE11A (0.60) PDE11APIK3CDPIK3CAPIK3CBMAPT
SCHEMBL5871831 0.91 PDE11A (0.57) PDE11APIK3CDPIK3CAPIK3CBCDK4
SCHEMBL5871598 0.91 PDE11A (0.58) PDE11APIK3CDPIK3CAPIK3CBCDK4
SCHEMBL8287870 0.90 PDE11A (0.56) PDE11APIK3CDPIK3CAPIK3CBCDK4
SCHEMBL8285164 0.89 PDE11A (0.55) PDE11APIK3CDPIK3CAPIK3CBCDK4
SCHEMBL8286050 0.89 PDE11A (0.54) PDE11AMAPTHSD17B10LMNAMAPK1
SCHEMBL8286054 0.89 PDE11A (0.54) PDE11AMAPTKDM4ETSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed